About
What it is and where it shows up.
Fenugreek powder is the ground form of dried seeds from Trigonella foenum-graecum, a leguminous herb native to South Asia and the Mediterranean region. It is used worldwide as a spice, flavouring agent, and botanical supplement, imparting a distinctive bitter-maple flavour to curries, spice blends, and food supplements.
Safety summary
The regulatory and scientific consensus.
Fenugreek is broadly recognized as safe at culinary spice doses with no formal ADI established and no IARC carcinogen classification. High or supplemental doses can significantly lower blood glucose and may interact with antidiabetic or anticoagulant medications. Uterotonic properties at supra-culinary doses make it inadvisable in large amounts during pregnancy, and cross-reactive allergic reactions have been documented in individuals with legume (peanut, chickpea, soybean) sensitivities.
Regulatory landscape
What food-safety regulators have decided.
| Jurisdiction | Status | Note |
|---|---|---|
| EFSA (European Food Safety Authority) (European Union) | Approved | Fenugreek seed powder (FEN 560) is listed in Annex IV of Regulation (EC) No 396/2005 (as amended by Commission Regulation (EU) 2016/805 of 20 May 2016), meaning no maximum residue levels are required when used as a plant protection active substance. As a food spice/flavouring, it is widely permitted across EU Member States under national food law; no E-number has been assigned. EU does not maintain a centralised authorisation procedure for botanicals used in food supplements — authorisation is a national competency of Member States.source |
| FSSAI (Food Safety and Standards Authority of India) (India) | Approved | Regulated as a standardized spice under FSS (Food Products Standards and Food Additives) Regulations, 2011, Regulation 5.8.11 (Fenugreek/Methi), with defined compositional and quality standards. Also listed in the FSSAI Nutraceuticals Compendium (2021) as a permissible botanical ingredient in health supplements, nutraceuticals, and functional foods when specific health benefit claims are made, subject to prior FSSAI approval.source |
| FDA (Food and Drug Administration) (United States) | Approved | Listed as GRAS under 21 CFR 182.10 (spices and other natural seasonings and flavorings) and 21 CFR 182.20 (natural flavoring substances). Also holds FEMA GRAS status (FEMA No. 2484) for use as a flavoring. No maximum use level is specified; limited to GMP.source |
Who should approach with care
Whose guidance would steer them away.
Pregnancy — High or supplemental doses of fenugreek have documented uterotonic properties that may stimulate uterine contractions and increase risk of preterm labour; culinary spice quantities are generally considered low-risk but large supplemental doses should be avoided.
Diabetes — Fenugreek can produce clinically significant reductions in blood glucose and may potentiate antidiabetic medications, increasing the risk of hypoglycaemia; patients on glucose-lowering therapy should consult a physician before supplemental use.
Infants — Fenugreek is sometimes used as a galactagogue, but active compounds may pass into breast milk and safety at supplemental doses for breastfed neonates and young infants is not well established.
Lactation — Supplemental fenugreek use during lactation has been reported to cause GI distress and fenugreek-like odour in infants; although used traditionally to stimulate milk supply, dose and safety evidence remain limited.
Other — Individuals with known IgE-mediated allergy to other legumes (peanuts, chickpeas, soybeans, lentils) are at risk of cross-reactive allergic reactions to fenugreek due to shared allergenic proteins; label vigilance is advised.
Research citations
The sources behind this verdict.
- 1FDA. 21 CFR Part 182, Subpart A, Section 182.10 – Spices and Other Natural Seasonings and Flavorings (GRAS). ecfr.gov
- 2EFSA. Scientific Opinion on the substantiation of a health claim related to Teestar™ (fenugreek seed extract) and reduction of post-prandial glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006, 2015. efsa.europa.eu
- 3PubMed. Fenugreek (Trigonella foenum-graecum L.): An overview of its botanical, agronomical, and health properties (Pharmacognosy Reviews, 2012), 2012. pubmed.ncbi.nlm.nih.gov
- 4EFSA. Conclusion on the peer review of the pesticide risk assessment of the active substance fenugreek seed powder (FEN 560), EFSA Journal 2010; 8(3):1448, 2010. efsa.europa.eu
- 5FSSAI. Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2010 – Regulation 5.8.11: Fenugreek (Methi), 2010. fssai.gov.in
Independently researched5 citations